Domain > access-to-insight.com

More information on this domain is in AlienVault OTX

Whois

Property	Value
Email	info@businesstools.de
NameServer	NS56.1UND1.DE
Created	2008-09-17 00:00:00
Changed	2016-02-09 00:00:00
Expires	2016-09-17 00:00:00
Registrar	1&1 INTERNET SE

DNS Resolutions

Date	IP Address
2024-12-22	217.160.0.83 (ClassC)
2025-01-13	104.21.16.1 (ClassC)
2025-03-06	104.21.32.1 (ClassC)
2025-05-08	104.21.48.1 (ClassC)
2025-05-17	104.21.112.1 (ClassC)
2025-06-10	104.21.96.1 (ClassC)
2025-10-01	104.21.44.191 (ClassC)
2025-11-27	172.67.203.61 (ClassC)

Port 443

HTTP/1.1 200 OKContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-aliveKeep-Alive: timeout15Date: Mon, 12 Feb 2024 09:55:38 GMTServer: Apache

!DOCTYPE html PUBLIC -//W3C//DTD HTML 4.01//EN http://www.w3.org/TR/html4/strict.dtd>html>head>title>Novo Nordisk - Your Access to Insight - Supporting global haemostasis research/title>base>meta http-equivimagetoolbar contentno>meta http-equivContent-Type contenttext/html; charsetUTF-8>meta namedescription contentAccess to Insight, the Novo Nordisk Haemostasis Grants & Awards Initiative, supports research and education in haemophilia and other bleeding disorders. The grants, awards and scholarships will support haemostasis research and training of physicians in the field of haemostasis/haemophilia clinical management.>meta namekeywords contentaccess to insight, access, insight, haemophilia, hemophilia, haemostasis, hemostasis, coagulation disorder, bleeding disorder, grant, award, scholarship, research, research funding, research support, training, education, physicians, Novo Nordisk, sponsorship>meta namelanguage contentenglisch>meta namerobots contentindex,follow>meta nameauthor contentNovo Nordisk Pharma AG>meta nameabstract contentAccess to Insight – the Novo Nordisk Haemostasis Grants & Awards Initiative – offers a series of exciting funding opportunities (grants, awards, scholarships) especially tailored to the needs of talented haemostasis physicians and researchers.>meta namedesigner contentFarben+Formen GmbH>meta namepublisher contentNovo Nordisk Pharma AG>meta namerevisit-After content7 days>meta namedistribution contentglobal>link relshortcut icon hrefnn_events.ico>link hrefcss/ati.css relstylesheet mediascreen typetext/css>!--if lt IE 7>	link hrefcss/ie_hacks.css relstylesheet mediaall typetext/css />!endif-->!--if gte IE 7>	link hrefcss/ie7_hacks.css relstylesheet mediaall typetext/css />!endif-->link hrefcss/print.css relstylesheet mediaprint typetext/css>script typetext/javascript src./js/menu.js?v202110111638>/script>script typetext/javascript src./js/jquery.js?v202110111638>/script>script typetext/javascript src./js/jquery.progressbar.min.js?v202110111638>/script>script typetext/java

Subdomains

Date	Domain	IP
www.access-to-insight.com	2025-01-23	104.21.80.1

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > access-to-insight.com

Is this malicious?

Whois

DNS Resolutions

Port 80

Port 443

Subdomains